HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTC: PWRM, www.Power3Medical.com), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for neurodegenerative disease, breast cancer and drug resistance, said today that it has taken another step in building its growing portfolio of intellectual property by converting a provisional patent application to a utility patent application.
